miR-217 regulates tumor growth and apoptosis by targeting the MAPK signaling pathway in colorectal cancer

作者: Nan Zhang , Canrong Lu , Lin Chen

DOI: 10.3892/OL.2016.5249

关键词:

摘要: MicroRNA (miR)-217 has been reported to participate in carcinogenesis and tumor progression several cancers; however, its expression biological functions colorectal cancer (CRC) are still unclear. The present study demonstrated that miR-217 was significantly higher matched adjacent noncancerous tissues than CRC (P<0.001). In addition, it observed low-grade exhibited greater of compared with high-grade (P<0.05). Kaplan-Meier survival Cox regression analyses revealed overall rates were poorer the low-expression group relative high-expression (P<0.005). Next, a potential target, mitogen-activated protein kinase (MAPK) 1, identified. Upregulation could downregulate MAPK1 expression. cells overexpressing cell growth inhibition by significant enhancement apoptosis vitro. further investigated MAPK signaling pathway verify mechanisms, KRAS Raf-1 downregulated miR-217-overexpressing RKO cells. Taken together, our results inhibits enhances CRC, this is associated downregulation signaling. These indicate promising therapeutic target for treatment CRC.

参考文章(43)
Darcy J. P. Bates, Lionel D. Lewis, Manipulating the apoptotic pathway: potential therapeutics for cancer patients. British Journal of Clinical Pharmacology. ,vol. 76, pp. 381- 395 ,(2013) , 10.1111/BCP.12193
J. M. Adams, The Bcl-2 Protein Family: Arbiters of Cell Survival Science. ,vol. 281, pp. 1322- 1326 ,(1998) , 10.1126/SCIENCE.281.5381.1322
Richard J. Orton, Oliver E. Sturm, Vladislav Vyshemirsky, Muffy Calder, David R. Gilbert, Walter Kolch, Computational modelling of the receptor-tyrosine-kinase-activated MAPK pathway Biochemical Journal. ,vol. 392, pp. 249- 261 ,(2005) , 10.1042/BJ20050908
Ahmed F. Abdel-Magid, ERK2 Inhibitors May Provide Treatment for Cancer. ACS Medicinal Chemistry Letters. ,vol. 4, pp. 576- 577 ,(2013) , 10.1021/ML400178Q
Emily K. Bergsland, Is More Not Better? Hematology/Oncology Clinics of North America. ,vol. 29, pp. 85- 116 ,(2015) , 10.1016/J.HOC.2014.09.002
Mitsuo Kato, Sumanth Putta, Mei Wang, Hang Yuan, Linda Lanting, Indu Nair, Amanda Gunn, Yoshimi Nakagawa, Hitoshi Shimano, Ivan Todorov, John J. Rossi, Rama Natarajan, TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nature Cell Biology. ,vol. 11, pp. 881- 889 ,(2009) , 10.1038/NCB1897
Michael P. Scheid, Kathryn M. Schubert, Vincent Duronio, Regulation of Bad Phosphorylation and Association with Bcl-xLby the MAPK/Erk Kinase Journal of Biological Chemistry. ,vol. 274, pp. 31108- 31113 ,(1999) , 10.1074/JBC.274.43.31108
Todd W Bauer, Francis R Spitz, Adjuvant and neoadjuvant chemoradiation therapy for primary colorectal cancer. Surgical Oncology-oxford. ,vol. 7, pp. 175- 181 ,(1998) , 10.1016/S0960-7404(99)00027-4
Lijun Ye, Gang Yuan, Fei Xu, Yueli Sun, Ziyan Chen, Miaohong Chen, Tianxiao Li, Pingping Sun, Shuxia Li, Jian Sun, The small-molecule compound BM-1197 inhibits the antiapoptotic regulators Bcl-2/Bcl-xL and triggers apoptotic cell death in human colorectal cancer cells Tumor Biology. ,vol. 36, pp. 3447- 3455 ,(2015) , 10.1007/S13277-014-2980-Z